197 results on '"Rao, Martin"'
Search Results
2. B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision Medicine?
3. Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
4. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
5. Ethnologie: Einführung in die Erforschung kultureller Vielfalt
6. Mutant Epitopes in Cancer
7. Latent TB Infection (LTBI) – Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground
8. Improving treatment outcomes for MDR-TB — Novel host-directed therapies and personalised medicine of the future
9. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
10. Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis
11. Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
12. Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
13. Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette–Guérin vaccination
14. Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model
15. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy
16. Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy
17. Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays
18. Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
19. Precision medicine in the clinical management of respiratory tract infections including multidrug-resistant tuberculosis: learning from innovations in immuno-oncology
20. T-Cell Therapy: Options for Infectious Diseases
21. B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis
22. Mutant Epitopes in Cancer
23. CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
24. Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas
25. Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
26. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
27. A novel F420-dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents
28. Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies
29. Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
30. An experimental investigation of the use of air jet vortex generators to control shock induced boundary layer separation
31. Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
32. Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies
33. Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine
34. World Tuberculosis Day March 24th 2019 Theme: “It’s TIME” — International Journal of Infectious Diseases Tuberculosis Theme Series
35. Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
36. Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
37. KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
38. The impact of inflationary cytomegalovirus‐specific memory T cells on anti‐tumour immune responses in patients with cancer
39. Progress in tuberculosis vaccine development and host-directed therapies?€'a state of the art review
40. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme
41. Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses
42. Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
43. Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
44. B cells or T cells in TB: a continuing conundrum
45. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 — “Wanted: Leaders for a TB-Free World. You can make history. End TB”
46. Increased IL-6 Levels Correlate with Severity of Lung Damage and Early Death in Tanzanian Patients with Pulmonary Tuberculosis
47. Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
48. Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
49. A novel F420-dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents
50. Tumor-infiltrating lymphocytes (TILs) from patients with glioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.